RS12483959 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:None]"
GWAS Studies (14)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Serum glutamic-pyruvic transaminase levels | — | OR: 1.12 | 2E-67 | PubMed |
| Serum glutamic-oxaloacetic transaminase levels | — | OR: 0.64 | 3E-67 | PubMed |
| Fatty liver | A | OR: 0.36 | 1E-30 | PubMed |
| Triacylglycerol(56:6)_[M+NH4]1+ levels | G | β: 0.08 | 6E-27 | PubMed |
| Triacylglycerol(56:5)_[M+NH4]1+ levels | T | OR: 0.11 | 6E-27 | PubMed |
| Metabolite levels | A | β: 0.004 | 2E-18 | PubMed |
| Triacylglycerol_56:6_[M+NH4]1+ levels | A | OR: 0.15 | 2E-15 | PubMed |
| Very low density lipoprotein cholesterol levels | — | OR: 0.55 | 1E-13 | PubMed |
| X-23641 levels | A | OR: 0.2 | 8E-13 | PubMed |
| Triacylglycerol_56:5_[M+NH4]1+ levels | A | OR: 0.13 | 3E-11 | PubMed |
| Triacylglycerol_58:7_[M+NH4]1+ levels | A | OR: 0.13 | 3E-10 | PubMed |
| AFP levels | — | β: 0.048 | 7E-9 | PubMed |
| Alanine aminotransferase levels | — | — | 6E-8 | PubMed |
| Accelerated lung function decline (FVC) and worsened/persistent change in fatty liver (pleiotropy) | A | OR: 1.39 | 3E-7 | PubMed |